Brendan M. Schulman


  • Wednesday, June 1, 2005
    The Supreme Court recently announced its much-anticipated decision in Dura Pharmaceuticals, Inc. v. Broudo, 125 S. Ct. 1627 (2005), addressing the pleading and proof burdens that private plaintiffs must carry on the issue of loss causation in actions under section 10(b) of the Securities Exchange Act of 1934 and S.E.C. Rule 10b-5. The narrow holding in Dura...